David Greenwood

David Greenwood currently serves on the Board of CohBar, Inc. a biopharma company and on the Board of Dark Horse Consulting, a cell and gene therapy consulting firm. Until its sale, he served as Chairman of the Board of Corium International, a drug development and delivery company.currently serves as Chairman of the Board of Directors of Corium International, a drug development and delivery company. He served as Executive Chairman from 2012 to 2015. In addition, Mr. Greenwood is an adviser to a number of public and private companies. Mr. Greenwood is a former Chief Executive Officer, Chief Financial Officer and Director of Geron Corporation, a biotechnology company in the fields of regenerative medicine and cancer. He was previously Chairman of the Board of Geron Bio-Med Limited, Chairman of the Board of TA Therapeutics, Ltd., a Board Director of ViaGen, Inc., Clone International, and Parnell Pharmaceuticals. He is currently on the President’s Task Force at Pacific Lutheran University where he also served on the Board of Regents on the Executive Committee and Chair of the Development Committee. From 1979 to 1995, Mr. Greenwood held various positions with JP Morgan & Co. Incorporated, an international banking firm. Mr. Greenwood holds a BA from Pacific Lutheran University and an MBA from Harvard Business School.